Semaglutide starts work by simulating GLP-1 hormone, increasing secretion of insulin, inhibiting glucagon release, overpowering appetite, gastric activity also slow down and leading to better glucose control and weight loss
Participants receiving the highest dose (12 mg weekly) achieved a mean body weight reduction of approximately 24% over 48 weeks results that exceeded those seen with currently approved agents at the time of publication
302,303,304,305 GLP-1R signaling, through PKA, inhibits this process, possibly by promoting IB stability or inhibiting its phosphorylation, thus reducing NF-B activation and nuclear translocation
also helps to control type 2 diabetes, but you take it as a once-daily pill
Not everyone needs the maximum dose to achieve their weight loss goals